Literature DB >> 16317535

Citrate and vitamin E blunt the shock wave-induced free radical surge in an in vitro cell culture model.

Fernando C Delvecchio1, Ricardo M Brizuela, Saeed R Khan, Karen Byer, Zaiquan Li, Pei Zhong, Glenn M Preminger.   

Abstract

Free radical formation plays a major role in shock wave lithotripsy induced renal damage. Moreover, previous studies suggest that free radicals may also promote de novo calcium oxalate crystallization of previously damaged urothelium. Citrate is a known inhibitor of renal stone formation and has also been used as a free radical scavenger. Using an in vitro model with Madin-Darby canine kidney (MDCK) cells, we investigated the influence of two free radical scavengers, citrate and vitamin E, on the prevention of the shock wave-induced free radical surge. Suspensions of MDCK cells were placed in containers for shock wave exposure. Six groups of six containers each were examined: (a) no scavengers 0 shocks, (b) no scavengers 100 shocks, (c) citrate 0 shocks, (d) citrate 100 shocks, (e) vitamin E 0 shocks, (f) vitamin E 100 shocks. An unmodified HM3 was used to deliver 100 shocks at 24 kV. The cell groups that were not shocked acted as the control group and were handled identically, except for the lack of shock wave exposure. After shock wave administration, the containers were emptied and cell suspensions were immediately centrifuged. The supernatant was examined for lactate dehydrogenase (LDH) and 8-isoprostane (8-IP), markers of cellular injury and free radical formation, respectively. Intracellular LDH uniformly increased in all groups exposed to shock wave energy. Similarly, 8-IP increased in all shocked groups. However, the 8-IP increase was significantly reduced when the free radical scavengers were employed. As citrate is a well-known inhibitor of calcium nephrolithiasis, its mechanism of action may be further enhanced, based on its ability to reduce free radical formation, by a protective effect on the urothelium. These data further support the use of citrate based medications during the peri-operative period of shock wave lithotripsy, not only to inhibit stone formation and facilitate fragment passage, but also to reduce the incidence of shock wave induced renal damage. Further studies are warranted to clinically test this hypothesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16317535     DOI: 10.1007/s00240-005-0506-2

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  23 in total

Review 1.  Management of residual stones.

Authors:  F C Delvecchio; G M Preminger
Journal:  Urol Clin North Am       Date:  2000-05       Impact factor: 2.241

2.  Oxalate and calcium oxalate crystals are injurious to renal epithelial cells: results of in vivo and in vitro studies.

Authors:  S Thamilselvan; S R Khan
Journal:  J Nephrol       Date:  1998 Mar-Apr       Impact factor: 3.902

3.  Shock wave lithotripsy causes ipsilateral renal injury remote from the focal point: the role of regional vasoconstriction.

Authors:  Fernando Delvecchio; Brian K Auge; Ravi Munver; Spencer A Brown; Ricardo Brizuela; Pei Zhong; Glenn M Preminger
Journal:  J Urol       Date:  2003-04       Impact factor: 7.450

4.  Oxalate and calcium oxalate mediated free radical toxicity in renal epithelial cells: effect of antioxidants.

Authors:  Sivagnanam Thamilselvan; Saeed R Khan; Mani Menon
Journal:  Urol Res       Date:  2002-11-22

5.  Quantitation of shock wave lithotripsy-induced lesion in small and large pig kidneys.

Authors:  P M Blomgren; B A Connors; J E Lingeman; L R Willis; A P Evan
Journal:  Anat Rec       Date:  1997-11

6.  Damaging effects of high energy shock waves on cultured Madin Darby canine kidney (MDCK) cells.

Authors:  W L Strohmaier; K H Bichler; P Deetjen; S Kleinknecht; M Pedro; D M Wilbert
Journal:  Urol Res       Date:  1990

7.  How to improve lithotripsy and chemolitholysis of brushite-stones: an in vitro study.

Authors:  D Heimbach; D Jacobs; A Hesse; S C Müller; P Zhong; G M Preminger
Journal:  Urol Res       Date:  1999-08

8.  The use of chemical treatments for improved comminution of artificial stones.

Authors:  D Heimbach; J Kourambas; P Zhong; J Jacobs; A Hesse; S C Mueller; F C Delvecchio; F H Cocks; G M Preminger
Journal:  J Urol       Date:  2004-05       Impact factor: 7.450

9.  Oxalate toxicity in LLC-PK1 cells: role of free radicals.

Authors:  C Scheid; H Koul; W A Hill; J Luber-Narod; L Kennington; T Honeyman; J Jonassen; M Menon
Journal:  Kidney Int       Date:  1996-02       Impact factor: 10.612

10.  Oxalate toxicity in LLC-PK1 cells, a line of renal epithelial cells.

Authors:  C Scheid; H Koul; W A Hill; J Luber-Narod; J Jonassen; T Honeyman; L Kennington; R Kohli; J Hodapp; P Ayvazian; M Menon
Journal:  J Urol       Date:  1996-03       Impact factor: 7.450

View more
  7 in total

Review 1.  Citrate chemistry and biology for biomaterials design.

Authors:  Chuying Ma; Ethan Gerhard; Di Lu; Jian Yang
Journal:  Biomaterials       Date:  2018-05-04       Impact factor: 12.479

Review 2.  Should we modify the principles of risk evaluation and recurrence preventive treatment of patients with calcium oxalate stone disease in view of the etiologic importance of calcium phosphate?

Authors:  Hans-Göran Tiselius
Journal:  Urolithiasis       Date:  2014-08-03       Impact factor: 3.436

Review 3.  Biomolecular mechanism of urinary stone formation involving osteopontin.

Authors:  Kenjiro Kohri; Takahiro Yasui; Atsushi Okada; Masahito Hirose; Shuzo Hamamoto; Yasuhiro Fujii; Kazuhiro Niimi; Kazumi Taguchi
Journal:  Urol Res       Date:  2012-11-06

Review 4.  The fat side of prostate cancer.

Authors:  Giorgia Zadra; Cornelia Photopoulos; Massimo Loda
Journal:  Biochim Biophys Acta       Date:  2013-04-02

5.  Citrate treatment reduces endothelial death and inflammation under hyperglycaemic conditions.

Authors:  Anna Bryland; Anders Wieslander; Ola Carlsson; Thomas Hellmark; Gabriela Godaly
Journal:  Diab Vasc Dis Res       Date:  2011-11-01       Impact factor: 3.291

6.  Pyrrolidine dithiocarbamate attenuate shock wave induced MDCK cells injury via inhibiting nuclear factor-kappa B activation.

Authors:  Xiang Li; Dalin He; Linlin Zhang; Yuquan Xue; Xinfa Cheng; Yong Luo
Journal:  Urol Res       Date:  2007-06-12

7.  Replacement of acetate with citrate in dialysis fluid: a randomized clinical trial of short term safety and fluid biocompatibility.

Authors:  Gunilla Grundström; Anders Christensson; Maria Alquist; Lars-Göran Nilsson; Mårten Segelmark
Journal:  BMC Nephrol       Date:  2013-10-09       Impact factor: 2.388

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.